Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M92.1Revenue (TTM) $M34.3Net Margin (%)-96.6Altman Z-Score-6.4
Enterprise Value $M163EPS (TTM) $-0.6Operating Margin %-81.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-96.1Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio5.2Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %-6.9Current Ratio5.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-49.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-149.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M64.9ROIC % (ttm)-97.7Gross Margin Increase y-yY

Gurus Latest Trades with ALIM

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ALIM is held by these investors:



ALIM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Myers C. DanielCEO 2017-03-10Sell21,172$1.392.16view
Roberts Calvin W.Director 2016-12-12Sell50,000$1.1127.93view
EISWIRTH RICHARD S JRPresident and CFO 2016-09-15Sell51,471$1.51-5.96view
BAVP, L.P.10% Owner 2016-04-21Sell478,673$2.59-45.17view
EISWIRTH RICHARD S JRCOO and CFO 2015-12-16Sell46,669$2.31-38.53view
Flynn James E 2015-12-08Buy272,249$3.01-52.82view
Flynn James E 2015-12-03Buy243,252$3-52.67view
Flynn James E 2015-11-06Buy73,250$2.98-52.35view
Flynn James E 2015-10-30Buy16,542$3-52.67view
Flynn James E 2015-10-28Buy59,342$3-52.67view

Press Releases about ALIM :

Quarterly/Annual Reports about ALIM:

    News about ALIM:

    Articles On GuruFocus.com
    Alimera Sciences Inc. (ALIM) President and CEO C. Daniel Myers sells 45,523 Shares Mar 16 2011 
    The Most Speculative Stocks on the Market: Harbinger, Kaching Kaching, Alimera Sciences, Star Scient Jul 29 2010 

    More From Other Websites
    ETFs with exposure to Alimera Sciences, Inc. : March 27, 2017 Mar 27 2017
    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Mar 14 2017
    Alimera Sciences, Inc. (ALIM) Looks Good: Stock Up 12.8% Mar 14 2017
    Alimera Sciences Signs Agreement for Exclusive Distributor of ILUVIEN® in Spain Mar 13 2017
    ALIMERA SCIENCES INC Financials Mar 09 2017
    Alimera Sciences to Present at the 29th Annual ROTH Conference Mar 07 2017
    ALIMERA SCIENCES INC Files SEC form 10-K, Annual Report Mar 03 2017
    Alimera Sciences to Present at the 37th Annual Cowen Health Care Conference Mar 03 2017
    Edited Transcript of ALIM earnings conference call or presentation 2-Mar-17 3:00pm GMT Mar 02 2017
    Alimera Sciences reports 4Q loss Mar 02 2017
    Alimera Sciences reports 4Q loss Mar 02 2017
    ALIMERA SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 01 2017
    Alimera Sciences Reports Record Fourth Quarter and Full Year 2016 Financial Results Mar 01 2017
    Q4 2016 Alimera Sciences Inc Earnings Release - After Market Close Mar 01 2017
    Alimera Sciences to Report Fourth Quarter 2016 Financial Results on March 1, 2017 Feb 23 2017
    Alimera Sciences and Knight Therapeutics Announce Filing of New Drug Submission for Iluvien® in... Feb 22 2017
    Alimera Sciences and Knight Therapeutics Announce Filing of New Drug Submission for Iluvien(R) in... Feb 22 2017
    Alimera Sciences Announces the Reimbursement of ILUVIEN® in Italy Feb 06 2017
    ETFs with exposure to Alimera Sciences, Inc. : January 11, 2017 Jan 11 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)